Amy Sims

18.8k total citations · 5 hit papers
76 papers, 7.2k citations indexed

About

Amy Sims is a scholar working on Infectious Diseases, Animal Science and Zoology and Molecular Biology. According to data from OpenAlex, Amy Sims has authored 76 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 35 papers in Animal Science and Zoology and 14 papers in Molecular Biology. Recurrent topics in Amy Sims's work include SARS-CoV-2 and COVID-19 Research (44 papers), Viral gastroenteritis research and epidemiology (36 papers) and Animal Virus Infections Studies (35 papers). Amy Sims is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (44 papers), Viral gastroenteritis research and epidemiology (36 papers) and Animal Virus Infections Studies (35 papers). Amy Sims collaborates with scholars based in United States, France and Netherlands. Amy Sims's co-authors include Ralph S. Baric, Mark R. Denison, Timothy P. Sheahan, Rachel L. Graham, Boyd L. Yount, Tomáš Cihlář, Joy Y. Feng, Raymond J. Pickles, Robert Jordan and Michael O. Clarke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Amy Sims

71 papers receiving 7.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

2020 1.2k citations Timothy P. Sheahan, Amy Sims et al. profile →
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

2018 1.0k citations Maria L. Agostini, Erica L. Andres et al. profile →
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture

2010 675 citations Aartjan J.W. te Velthuis, Sjoerd H. E. van den Worm et al. PLoS Pathogens profile →
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase

2019 372 citations Rachel L. Graham, Kenneth H. Dinnon et al. Antiviral Research profile →
Small-Molecule Antiviral β- d - N ⁴ -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance

2019 255 citations Maria L. Agostini, Andrea J. Pruijssers et al. Journal of Virology profile →

Peers

Countries citing papers authored by Amy Sims

Since Specialization

Citations

This map shows the geographic impact of Amy Sims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Sims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Sims more than expected).

Fields of papers citing papers by Amy Sims

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Sims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Sims. The network helps show where Amy Sims may publish in the future.

Co-authorship network of co-authors of Amy Sims

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Sims. A scholar is included among the top collaborators of Amy Sims based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Sims. Amy Sims is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteome-wide characterization of PTMs reveals host cell responses to viral infection and identifies putative antiviral drug targets 2025 ·Frontiers in Immunology ·Xiaolu Li, (unknown), Ashley N. Ives, (unknown), Katrina M. Waters, Weijun Qian, Amy Sims, Tong Zhang	0
2	Charting the Impact of Maternal Antibodies and Repeat Exposures on Sapovirus Immunity in Early Childhood From a Nicaraguan Birth Cohort 2024 ·The Journal of Infectious Diseases ·Filemón Bucardo, Michael L. Mallory, Fredman González, Yaoska Reyes, Nadja A. Vielot, Boyd L. Yount, Amy Sims, (unknown), Kaitlyn Cross, (unknown), (unknown), Jan Vinjé, Ralph S. Baric, Lisa C. Lindesmith, Sylvia Becker‐Dreps	2
3	Metatranscriptomics analysis reveals a novel transcriptional and translational landscape during Middle East respiratory syndrome coronavirus infection 2023 ·iScience ·Ethan J. Fritch, Wes Sanders, Amy Sims, Laura E. Herring, Natalie K. Barker, Athena Schepmoes, Karl Weitz, (unknown), Dirk P. Dittmer, Lee M. Graves, Richard Smith, Katrina M. Waters, Nathaniel J. Moorman, Ralph S. Baric, Rachel L. Graham	1
4	Genetic Dissection of the Regulatory Mechanisms of Ace2 in the Infected Mouse Lung 2021 ·Frontiers in Immunology ·Fuyi Xu, Jun Gao, Silke Bergmann, Amy Sims, David G. Ashbrook, Ralph S. Baric, Yan Cui, Colleen B. Jonsson, Kui Li, Robert W. Williams, Klaus Schughart, Lu Lu	14
5	Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis 2021 ·Algal Research ·(unknown), Michael H. Huesemann, Scott Edmundson, Amy Sims, Brett L. Hurst, Sherry L. Cady, (unknown), Jacob Freeman, Adam C. Berger, Song Gao	52
6	Small-Molecule Antiviral β- d - N ⁴ -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance breakdown → 2019 ·Journal of Virology ·Maria L. Agostini, Andrea J. Pruijssers, James D. Chappell, Jennifer Gribble, Xiaotao Lu, Erica L. Andres, Gregory R. Bluemling, Mark A. Lockwood, Timothy P. Sheahan, Amy Sims, Michael G. Natchus, Manohar Saindane, Alexander A. Kolykhalov, George R. Painter, Ralph S. Baric, Mark R. Denison	255
7	Metabolite, Protein, and Lipid Extraction (MPLEx): A Method that Simultaneously Inactivates Middle East Respiratory Syndrome Coronavirus and Allows Analysis of Multiple Host Cell Components Following Infection 2019 ·Methods in molecular biology ·Carrie Nicora, Amy Sims, Kent Bloodsworth, Young‐Mo Kim, Ronald Moore, Jennifer Kyle, Ernesto Nakayasu, Thomas Metz	15
8	Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference 2019 ·Antiviral Research ·John H. Beigel, Hannah Nam, (unknown), Amy E. Krafft, William L. Ince, Samer S. El‐Kamary, Amy Sims	124
9	Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis 2017 ·mSphere ·Vineet D. Menachery, Lisa E. Gralinski, Hugh Mitchell, Kenneth H. Dinnon, Sarah R. Leist, Boyd L. Yount, Rachel L. Graham, Eileen T. McAnarney, Kelly G. Stratton, Adam S. Cockrell, Kari Debbink, Amy Sims, Katrina M. Waters, Ralph S. Baric	86
10	Culturing the Unculturable: Human Coronavirus HKU1 Infects, Replicates, and Produces Progeny Virions in Human Ciliated Airway Epithelial Cell Cultures 2010 ·Journal of Virology ·Krzysztof Pyrć, Amy Sims, Ronald Dijkman, Maarten F. Jebbink, (unknown), Damon Deming, Eric Donaldson, Astrid Vabret, Ralph S. Baric, Lia van der Hoek, Raymond J. Pickles	101
11	Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture breakdown → 2010 ·PLoS Pathogens ·Aartjan J.W. te Velthuis, Sjoerd H. E. van den Worm, Amy Sims, Ralph S. Baric, Eric J. Snijder, Martijn J. van Hemert	675
12	Systematic Assembly and Genetic Manipulation of the Mouse Hepatitis Virus A59 Genome 2008 ·Methods in molecular biology ·Eric Donaldson, Amy Sims, Ralph S. Baric	5
13	SARS coronavirus replicase proteins in pathogenesis 2007 ·Virus Research ·Rachel L. Graham, (unknown), Lance D. Eckerle, Amy Sims, Mark R. Denison	105
14	Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants 2006 ·PLoS Medicine ·Damon Deming, Timothy P. Sheahan, Mark T. Heise, Boyd L. Yount, Nancy Davis, Amy Sims, Mehul S. Suthar, Jack R. Harkema, Alan C. Whitmore, Raymond J. Pickles, Ande West, Eric Donaldson, Kristopher M. Curtis, Robert E. Johnston, Ralph S. Baric	193
15	The NSP2 Proteins of Mouse Hepatitis Virus and Sars Coronavirus are Dispensable for Viral Replication 2006 ·Advances in experimental medicine and biology ·Rachel L. Graham, Amy Sims, Ralph S. Baric, Mark R. Denison	22
16	Mutational Analysis of MHV-A59 Replicase Protein-NSP10 2006 ·Advances in experimental medicine and biology ·Eric Donaldson, Amy Sims, Damon Deming, Ralph S. Baric	2
17	Sars Coronavirus Accessory ORFs Encode Luxury Functions 2006 ·Advances in experimental medicine and biology ·Matthew B. Frieman, Boyd L. Yount, Amy Sims, Damon Deming, Thomas E. Morrison, (unknown), Mark R. Denison, Mark T. Heise, Ralph S. Baric	14
18	Renilla Luciferase as a Reporter to Assess SARS-CoV mRNA Transcription Regulation and Efficacy of ANTI-SARS-CoV Agents 2006 ·Advances in experimental medicine and biology ·Rhonda Roberts, Boyd L. Yount, Amy Sims, Susan C. Baker, Ralph S. Baric	5
19	[Serological study on toxoplasmosis and other parasitoses on Easter Island]. 1998 ·PubMed ·(unknown), Adriana Mosca, Sílvia Helena Marques da Silva, Amy Sims, (unknown), (unknown), (unknown)	0
20	Processing of the MHV-A59 Gene 1 Polyprotein by the 3C-Like Proteinase 1998 ·Advances in experimental medicine and biology ·Mark R. Denison, Amy Sims, C A Gibson, Xiao Lu	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact